Effects of imperatorin on scopolamine-induced cognitive impairment and oxidative stress in mice

Psychopharmacology

Volumn 232, Issue 5, 2015, Pages 931-942

  Budzynska, Barbara ^a   Boguszewska Czubara, Anna ^a   Kruk Slomka, Marta ^a   Skalicka Wozniak, Krystyna ^a   Michalak, Agnieszka ^a   Musik, Irena ^a   Biala, Grazyna ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Alzheimer; Animal model; Antioxidant; Scopolamine

Indexed keywords

GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; MALONALDEHYDE; PENTOSALEN; RIVASTIGMINE; SCOPOLAMINE; SUPEROXIDE DISMUTASE; FUROCOUMARIN DERIVATIVE; PLANT EXTRACT; SCOPOLAMINE BROMIDE;

ALZHEIMER DISEASE; ANGELICA ARCHANGELICA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DRUG DETERMINATION; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG ISOLATION; ENZYME ACTIVITY; ENZYME ASSAY; HIPPOCAMPUS; LATENT PERIOD; LEARNING; LIPID PEROXIDATION; LOCOMOTION; MALE; MEMORY CONSOLIDATION; MEMORY DISORDER; MOUSE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PASSIVE AVOIDANCE; PASSIVE AVOIDANCE TEST; PROTEIN DETERMINATION; ANIMAL; BRAIN; CHEMICALLY INDUCED; COGNITION; DISEASE MODEL; DRUG EFFECTS; MEMORY; MEMORY DISORDERS;

ALZHEIMER DISEASE; ANIMALS; BRAIN; COGNITION; DISEASE MODELS, ANIMAL; FUROCOUMARINS; MALE; MEMORY; MEMORY DISORDERS; MICE; OXIDATIVE STRESS; PLANT EXTRACTS; SCOPOLAMINE HYDROBROMIDE;

EID: 84922790051     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-014-3728-6     Document Type: Article

References (60)

1. Abed MJ, de las Heras B, Silvan AM, Pascual R, Bermejo P, Rodriquez B, Villar AM (2001) Effects of furocoumarins from Cachrys trifida on some macrophage functions. J Pharm Pharmacol 53:1163-1168
2. Allami N, Javadi-Paydar M, Rayatnia F, Sehhat K, Rahimian R, Norouzi A, Dehpour AR (2011) Suppression of nitric oxide synthesis by L-NAME reverses the beneficial effects of pioglitazone on scopolamine-induced memory impairment in mice. Eur J Pharmacol 650:240-248
3. Baek NI, Ahn EM, Kim HY, Park YD (2000) Furanocoumarins from the root of Angelica dahurica. Arch Pharmacol Res 23:467-470
4. Ban HS, Lim SS, Suzuki K, Jung SH, Lee S, Lee YS, Shin KH, Ohuchi K (2003) Inhibitory effects of furanocoumarins isolated from the roots of Angelica dahurica on prostaglandin E2 production. Plant Med 69:408-441
5. Blake MG, Krawczyk MC, Baratti CM, Boccia M (2014) Neuropharmacology of memory consolidation and reconsolidation: Insights on central cholinergic mechanisms. J Physiol Paris S0928-4257(14):00016-3
6. Bonda DJ, Wang X, Perry G, Nunomura A, Tabaton M, Zhu X, Smith MA (2010) Oxidative stress in Alzheimer disease: a possibility for prevention. Neuropharmacology 59:290-294
7. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
8. Buckingham SD, Jones AK, Brown LA, Sattelle DB (2009) Nicotinic acetylcholine receptor signalling: Roles in Alzheimer's disease and amyloid neuroprotection. Pharmacol Rev 61:39-61
9. Budzynska B, Kruk-Slomka M, Skalicka-Wozniak K, Biala G, Glowniak K (2012) The effects of imperatorin on anxiety and memory-related behavior in male Swiss mice. Exp Clin Psychopharmacol 20:25-32
10. Budzynska B, Boguszewska-Czubara A, Kruk-Słomka M, Skalicaka-Wozniak K, Michalak A, Musik I, Biala G, Głowniak K (2013) Effects of imperatorin on nicotine-induced anxiety- and memory-related responses and oxidative stress in mice. Physiol Behav 122:46-55
11. Canal N, Imbimbo BP (1996) Relationship between pharmacodynamic activity and cognitive effects of eptastigmine in patients with Alzheimer's disease. Eptastigmine Study Group. Clin Pharmacol Therap 60:218-228
12. Cao YJ, He X, Wang N, He LC (2013) Effects of imperatorin, the active component from Radix Angelicae (Baizhi), on the blood pressure and oxidative stress in 2 K,1C hypertensive rats. Phytomedicine 20:1048-1054
13. Chimakurthy J, Talasila M (2010) Effects of curcumin on pentylenetetrazole-induced anxiety-like behaviors and associated changes in cognition and monoamine levels. Psychol Neurosci 3:239-244
14. Chintoh A, Fulton J, Koziel N, Aziz M, Sud M, Yeomans JS (2003) Role of cholinergic receptors in locomotion induced by scopolamine and oxotremorine-M. Pharmacol Biochem Behav 76:53-61
15. Choi SY, Ahn EM, Song MC, Kim DW, Kang JH, Kwon OS, Kang TC, Baek NI (2005) In vitro GABA-transaminase inhibitory compounds from the root of Angelica dahurica. Phytotherap Res 19:839-845
16. Deiana S, Harrington CR, Wischik CM, Riedel G (2009) Methylthioninium chloride reverses cognitive deficits induced by scopolamine: Comparison with rivastigmine. Psychopharmacology (Berl) 202(1-3):53-65
17. Ding Q, Dimayuga E, Keller JN (2007) Oxidative damage, protein synthesis, and protein degradation in Alzheimer's disease. Curr Alzheimer Res 4:73-79
18. El-Sherbiny DA, Khalifa AE, Attia AS, Eldenshary E-D (2003) Hypericum perforatum extract demonstrates antioxidant properties against elevated rat brain oxidative status induced by amnestic dose of scopolamine. Pharmacol Biochem Behav 76:525-533
19. Fan Y, Hu J, Li J, Yang Z, Xin X, Wang J, Ding J, Geng M (2005) Effect of acidic oligosaccharide sugar chain on scopolamine-induced memory impairment in rats and its related mechanisms. Neurosci Lett 374:222-226
20. Fayuk D, Yakel JL (2004) Regulation of nicotinic acetylcholine receptor channel function by acetylcholinesterase inhibitors in rat hippocampal CA1 interneurons. Mol Pharmacol 66:658-666
21. Fylaktakidou KC, Hadjipavlou-Litina DJ, Litinas KE, Nicolaides DN (2004) Natural and synthetic coumarin derivatives with anti-inflammatory/antioxidant activities. Curr Pharm Des 10:3813-3833
22. Garcia-Argaez AN, Ramirez Apan TO, Parra Delgado H, Velazquez G, Martinez-Vazquez M (2000) Anti-inflammatory activity of coumarins from Decatropis bicolor on TPA ear mice model. Plant Med 66:279-281
23. Gholamreza P, Pratt JA, Nima D (2002) Effects of low-dose scopolamine on locomotor activity: no dissociation between cognitive and non-cognitive effects. Neurosci Res Comm 31:165-174
24. Gilgun-Sherki Y, Melamed E, Offen D (2003) Antioxidant treatment in Alzheimer's disease: Current state. J Mol Neurosci 21:1-11
25. Giridharan VV, Thandavarayan RA, Sato S, Ko KM, Konishi T (2011) Prevention of scopolamine-induced memory deficits by schisandrin B, an antioxidant lignan from Schisandra chinensis in mice. Free Radic Res 45:950-958
26. Goldberg DM, Spooner RJ (1983) Methods of enzymatic analysis. HV Bergmeyen (ed) (3rd ed)Verlog Chemie, Deerfield Beach, 258-265
27. Gupta R, Gupta LK, Mediratta PK, Bhattacharya SK (2012) Effect of resveratrol on scopolamine-induced cognitive impairment in mice. Pharmacol Rep 64(2):438-444
28. He JY, Zhang W, He LC, Cao YX (2007) Imperatorin induces vasodilatation possibly via inhibiting voltage dependent calcium channel and receptor-mediated Ca2+ influx and release. Eur J Pharmacol 573:170-175
29. Javadi-Paydar M, Zakeri M, Norouzi A, Rastegar H, Mirazi N, Dehpour A (2012) Involvement of nitric oxide in granisetron improving effect on scopolamine-induced memory impairment in mice. Brain Res Rev 1429:61-71
30. Kanwal A, Mehla J, Kuncha M, Naidu VGM, Gupta YK, Sistla R (2010) Anti-amnesic activity of vitex negundo in scopolamine induced amnesia in rats. Pharmacol Pharm 1:1-8
31. Kawaii S, Tomono Y, Ogawa K, Sugiura M, Yano M, Yoshizawa Y, Ito C, Furukawa H (2001) Antiproliferative effect of isopentenylated coumarins on several cancer cell lines. Anticancer Res 21:1905-1911
32. Kleiner HE, Vulimiri SV, Starost MF, Reed MJ, DiGiovanni J (2002) Oral administration of the citrus coumarin, isopimpinellin, blocks DNA adduct formation and skin tumor initiation by 712-dimethylbenz[a]anthracene in SENCAR mice. Carcinogenesis 23:1667-1675
33. Knoppman D (2001) Pharmacotherapy for Alzheimer's disease. Curr Neurol Neurosci Rep 1:428-432
34. Kontogiorgis CA, Savvoglou K, Hadjipavlou-Litina DJ (2006) Antiinflammatory and antioxidant evaluation of novel coumarin derivatives. J Enzyme Inhib Med Chem 21:21-29
35. Kostova I (2006) Synthetic and natural coumarins as antioxidants. Mini Rev Med Chem 6:365-374
36. Kruk M, Tendera K, Biała G (2011) Memory-related effects of cholinergic receptor ligands in mice as measured by the elevated plus maze test. Pharmacol Rep 63:1372-1382
37. Ledwozyw A, Michalak J, Stępień A, Kadziołka A (1986) The relationship between plasma triglycerides, cholesterol, total lipids and lipid peroxidation products during human atherosclerosis. Clin Chim Acta 155:275-283
38. Loizzo MR, Tundis R, Menichini F (2008) Natural products and their derivatives as cholinesterase inhibitors in the treatment of neurodegenerative disorders: an update. Curr Med Chem 15:1209-1228
39. Łuszczki JJ, Głowniak K, Czuczwar SJ (2007) Time-course and dose-response relationships of imperatorin in the mouse maximal electroshock seizure threshold model. Neurosci Res 59:18-22
40. Łuszczki JJ, Wojda E, Andres-Mach M, Cisowski W, Glensk M, Głowniak K, Czuczwar SJ (2009) Anticonvulsant and acute neurotoxic effects of imperatorin, osthole and valproate in the maximal electroshock seizure and chimney tests in mice: a comparative study. Epilepsy Res 85:293-299
41. McGaugh JL, Introini-Collison IB, Cahill LF, Castellano C, Dalmaz C, Parent MB, Williams CL (1993) Neuromodulatory systems and memory storage: Role of the amygdala. Behav Brain Res 58:81-90
42. Nomura Y, Nishiyama N, Saito H, Matsuki N (1994) Role of cholinergic neurotransmission in the amygdala on performances of passive avoidance learning in mice. Biol Pharm Bull 17:490-494
43. Pachauri SD, Tota S, Khandelwal K, Verma PR, Nath C, Hanif K, Shukla R, Saxena JK, Dwivedi AK (2012) Protective effect of fruits of Morinda citrifolia L. on scopolamine induced memory impairment in mice: a behavioral, biochemical and cerebral blood flow study. J Ethnopharmacol 139:34-41
44. Paglia DE, Valentine WN (1967) Studies on the quantitative and qualitative characterization of erythrocyte gluthatione peroxidase. J Lab Clin Med 70:1158-1169
45. Power AE, Vazdarjanova A, McGaugh JL (2003) Muscarinic cholinergic influences in memory consolidation. Neurobiol Learn Mem 80:178-193
46. Raja SB, Murali MR, Ropa K, Devaraj SN (2011) Imperatorin a furocoumarin inhibits periplasmic Cu-Zn SOD of Shigella dysenteriae their by modulates its resistance towards phagocytosis during host pathogen interaction. Biomed Pharmacother 65:560-568
47. Rountree SD, Chan W, Pavlik VN, Darby EJ, Siddiqui S, Doody RS (2009) Persistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer disease. Alzheimers Res Ther 1:7
48. Sancho R, Marquez N, Gomez-Gonzalo M, Calzado MA, Bettoni G, Coiras MT, Alcami J, Lopez-Cabrera M, Appendino G, Munoz E (2004) Imperatorin inhibits HIV-1 replication through an Sp1-dependent pathway. J Biol Chem 279:37349-37359
49. Schmeller T, Sporer F, Sauerwein M, Wink M (1995) Binding of tropane alkaloids to nicotinic and muscarinic acetylcholine receptors. Pharmazie 50:493-495
50. Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT (2011) Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Biol 1:a006189
51. Smith DG, Cappai R, Barnham KJ (2007) The redox chemistry of the Alzheimer's disease amyloid beta peptide. Biochim Biophys Acta 768:1976-1990
52. Snowden JS, Thompson JC, Stopford CL, Richardson AM, Gerhard A, Neary D, Mann DM (2011) The clinical diagnosis of early-onset dementias: Diagnostic accuracy and clinicopathological relationships. Brain 134:2478-2492
53. Sugaya K, Giacobini E, Chiappinelli VA (1990) Nicotinic acetylcholine receptor subtypes in human frontal cortex: Changes in Alzheimer's disease. J Neurosci 27:349-359
54. Sun J, Chi G, Soromou LW, Chen N, Guan M, WuQ WD, Li H (2012) Preventive effect of imperatorin on acute lung injury induced by lipopolysaccharide in mice. Int Immunopharmacol 14:369-374
55. Terry AV Jr, Buccafusco JJ (2003) The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: Recent challenges and their implications for novel drug development. J Pharmacol Exp Ther 306:821-827
56. Tsuji M, Takeda H, Matsumiya T (2003) Modulation of passive avoidance in mice by the 5-HT1A receptor agonist flesinoxan: Comparison with the benzodiazepine receptor agonist diazepam. Neuropsychopharmacology 28:664-674
57. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39:44-84
58. Venault P, Chapouthier G, de Carvalho LP, Simiand J, Morre M, Dodd RH, Rossier J (1986) Benzodiazepine impairs and beta-carboline enhances performance in learning and memory tasks. Nature 321:864-866
59. Vianna DR, Bubols G, Meirelles G, Silva BV, da Rocha A, Lanznaster M, Monserrat JM, Garcia SC, von Poser G, Eifler-Lima VL (2012) Evaluation of the antioxidant capacity of synthesized coumarins. Int J Mol Sci 13:7260-7270
60. Walton NM, Shin K, Tajinda CL, Heusner JH, Kogan S, Miyake CQ, Tamura K (2012) Adult neurogenesis transiently generates oxidative stress. PLoS One 7:e35264